Grant: CIHR - ICR / Cancer Research Society Partnership - Research Grants
University of Guelph
$59,990.00
Preventing Breast Cancer Metastasis by Disrupting MT1-MMP Trafficking
EF 2020-21
Résumé
The ability of malignant tumour cells to degrade extracellular matrix (ECM) and invade neighboring tissue is crucial to the metastatic spread of tumours, ultimately contributing to the vast majority of cancer-caused deaths. Degradation of ECM proteins is mediated by matrix metalloproteinases (MMPs), and evidence indicates that membrane type 1-matrix metalloproteinase (MT1-MMP) is a central regulator of invasion in aggressive tumours, including breast cancers. Herein, we propose to define the molecular mechanisms that control the trafficking of MT1-MMP to sites of ECM degradation in breast cancer cells, and how this contributes to tumour progression in vivo. Using the human mammary tumour cell line MDA-MB-231, we have determined that Syntaxin4 (Stx4), a t-SNARE, is required for MT1-MMP trafficking, and the metastatic spread of tumour cells in a murine xenograft model. [SNARE: soluble NSF attachment protein receptors; NSF: N-ethylmaleimide-sensitive factor.] We also found that perturbing the interaction between Stx4 and Munc18c, an S/M protein family member that regulates Stx4, impairs trafficking of MT1-MMP and tumour cell invasion in vitro. These findings are the first to indicate that tumour cell invasion can be regulated by the interaction of Stx4-Munc18c, and suggest this interaction may be a regulatory point in the process of cell invasion. We now plan to define how the Stx4-Munc18c interaction regulates trafficking of MT1-MMP and metastatic spread of MDA-MB-231 cells in vivo, and the role of this interaction in other types of breast cancer cells and tissue samples. We will also identify amino acids in the N-terminal region of Stx4 that are required for its interaction with Munc18c, to spur future efforts aimed at targeting this interaction therapeutically. The specific goal of the research proposed here is to elucidate the molecular mechanisms through which Stx4 and Munc18c regulate MT1-MMP-mediated cell invasion and mammary tumour progression in vivo. Three aims are proposed: (1) Define Stx4-Munc18c function in MT1-MMP trafficking and metastasis, (2) Identify amino acids required for interaction of Stx4 and Munc18c, and (3) Analysis of Stx4-Munc18c interaction in different breast cancer types. In aim #1, Stx4-Munc18c interaction will be disrupted in MDA-MB-231 cells, and changes to trafficking of MT1-MMP will be examined in vitro, and effects on tumour progression will studied using a mouse xenograft model. In aim #2, mutations in the N-terminal region of Stx4 will be generated and used to assess binding to Munc18c. In aim #3, the interaction of Stx4 and Munc18c will examined in panels of breast cancer cell lines and tumour tissues.
Programme
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
453440
Name
Coppolino Marc G
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Preventing Breast Cancer Metastasis by Disrupting MT1-MMP Trafficking
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$59,990
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Keyworddelim
Metastasis; Tumour Progression
Abstract
The ability of malignant tumour cells to degrade extracellular matrix (ECM) and invade neighboring tissue is crucial to the metastatic spread of tumours, ultimately contributing to the vast majority of cancer-caused deaths. Degradation of ECM proteins is mediated by matrix metalloproteinases (MMPs), and evidence indicates that membrane type 1-matrix metalloproteinase (MT1-MMP) is a central regulator of invasion in aggressive tumours, including breast cancers. Herein, we propose to define the molecular mechanisms that control the trafficking of MT1-MMP to sites of ECM degradation in breast cancer cells, and how this contributes to tumour progression in vivo. Using the human mammary tumour cell line MDA-MB-231, we have determined that Syntaxin4 (Stx4), a t-SNARE, is required for MT1-MMP trafficking, and the metastatic spread of tumour cells in a murine xenograft model. [SNARE: soluble NSF attachment protein receptors; NSF: N-ethylmaleimide-sensitive factor.] We also found that perturbing the interaction between Stx4 and Munc18c, an S/M protein family member that regulates Stx4, impairs trafficking of MT1-MMP and tumour cell invasion in vitro. These findings are the first to indicate that tumour cell invasion can be regulated by the interaction of Stx4-Munc18c, and suggest this interaction may be a regulatory point in the process of cell invasion. We now plan to define how the Stx4-Munc18c interaction regulates trafficking of MT1-MMP and metastatic spread of MDA-MB-231 cells in vivo, and the role of this interaction in other types of breast cancer cells and tissue samples. We will also identify amino acids in the N-terminal region of Stx4 that are required for its interaction with Munc18c, to spur future efforts aimed at targeting this interaction therapeutically. The specific goal of the research proposed here is to elucidate the molecular mechanisms through which Stx4 and Munc18c regulate MT1-MMP-mediated cell invasion and mammary tumour progression in vivo. Three aims are proposed: (1) Define Stx4-Munc18c function in MT1-MMP trafficking and metastasis, (2) Identify amino acids required for interaction of Stx4 and Munc18c, and (3) Analysis of Stx4-Munc18c interaction in different breast cancer types. In aim #1, Stx4-Munc18c interaction will be disrupted in MDA-MB-231 cells, and changes to trafficking of MT1-MMP will be examined in vitro, and effects on tumour progression will studied using a mouse xenograft model. In aim #2, mutations in the N-terminal region of Stx4 will be generated and used to assess binding to Munc18c. In aim #3, the interaction of Stx4 and Munc18c will examined in panels of breast cancer cell lines and tumour tissues.
Competitiondate
202103
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Coppolino, Marc G
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Cancer Research~ $59,990~ $0~